PLXProtalix BioTherapeutics, Inc.
- Market cap
- $205.46M
- as of 2026-10-23
- Latest close
- $2.55
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-03
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Schwartz Aharon | Sep 3 | Sep 9 | A · derivative | 17,000 | $2.59 | $44,030 | 17,000 | No | Form 4 |
| Schwartz Aharon | Sep 3 | Sep 9 | A · derivative | 8,500 | $0.00 | $0 | 8,500 | No | Form 4 |
| Bar-Shalev Amos | Sep 3 | Sep 4 | A · derivative | 17,000 | $2.59 | $44,030 | 17,000 | No | Form 4 |
| Bar-Shalev Amos | Sep 3 | Sep 4 | A · derivative | 8,500 | $0.00 | $0 | 8,500 | No | Form 4 |
| Boudes Pol F | Sep 3 | Sep 4 | A · derivative | 17,000 | $2.59 | $44,030 | 17,000 | No | Form 4 |
| Boudes Pol F | Sep 3 | Sep 4 | A · derivative | 8,500 | $0.00 | $0 | 8,500 | No | Form 4 |
| Melincoff Gwen A | Sep 3 | Sep 4 | A · derivative | 17,000 | $2.59 | $44,030 | 17,000 | No | Form 4 |
| Melincoff Gwen A | Sep 3 | Sep 4 | A · derivative | 8,500 | $0.00 | $0 | 8,500 | No | Form 4 |
| Naos YaronSr. VP & COO | Sep 3 | Sep 4 | A · derivative | 112,000 | $2.59 | $290,080 | 112,000 | No | Form 4 |
| Naos YaronSr. VP & COO | Sep 3 | Sep 4 | A · derivative | 56,000 | $0.00 | $0 | 56,000 | No | Form 4 |
| Bashan DrorPRESIDENT AND CEO | Sep 3 | Sep 4 | A · derivative | 320,000 | $2.59 | $828,800 | 320,000 | No | Form 4 |
| Bashan DrorPRESIDENT AND CEO | Sep 3 | Sep 4 | A · derivative | 160,000 | $0.00 | $0 | 160,000 | No | Form 4 |
| Forster Eliot | Sep 3 | Sep 4 | A · derivative | 17,000 | $2.59 | $44,030 | 17,000 | No | Form 4 |
| Forster Eliot | Sep 3 | Sep 4 | A · derivative | 8,500 | $0.00 | $0 | 8,500 | No | Form 4 |
| Ben Zvi Shmuel | Sep 3 | Sep 4 | A · derivative | 17,000 | $2.59 | $44,030 | 17,000 | No | Form 4 |
| Ben Zvi Shmuel | Sep 3 | Sep 4 | A · derivative | 8,500 | $0.00 | $0 | 8,500 | No | Form 4 |
| Elze Christian | Sep 3 | Sep 4 | A · derivative | 17,000 | $2.59 | $44,030 | 17,000 | No | Form 4 |
| Elze Christian | Sep 3 | Sep 4 | A · derivative | 8,500 | $0.00 | $0 | 8,500 | No | Form 4 |
| Bashan DrorPRESIDENT AND CEO | Dec 19, 2025 | Dec 23, 2025 | P | 56,000 | $1.81 | Purchase +$101,360 | 188,516 | No | Form 4 |
| Bar-Shalev Amos | Nov 18, 2025 | Nov 19, 2025 | S | 168 | $1.87 | Sale −$314 | not reported | No | Form 4 |
| Bashan DrorPRESIDENT AND CEO | Sep 3, 2025 | Sep 4, 2025 | A | 195,000 | not reported | not reported | 2,344,418 | No | Form 4 |
| Bashan DrorPRESIDENT AND CEO | Sep 3, 2025 | Sep 4, 2025 | A · derivative | 340,000 | $1.64 | $557,600 | 340,000 | No | Form 4 |
| Naos YaronSr. VP, Operations | Sep 3, 2025 | Sep 4, 2025 | A | 25,000 | not reported | not reported | 225,817 | No | Form 4 |
| Naos YaronSr. VP, Operations | Sep 3, 2025 | Sep 4, 2025 | A · derivative | 50,000 | $1.64 | $82,000 | 50,000 | No | Form 4 |
| Bar-Shalev Amos | Sep 3, 2025 | Sep 4, 2025 | A | 7,500 | not reported | not reported | 7,500 | No | Form 4 |
| Bar-Shalev Amos | Sep 3, 2025 | Sep 4, 2025 | A · derivative | 15,000 | $1.64 | $24,600 | 15,000 | No | Form 4 |
| Ben Zvi Shmuel | Sep 3, 2025 | Sep 4, 2025 | A | 7,500 | not reported | not reported | 7,500 | No | Form 4 |
| Ben Zvi Shmuel | Sep 3, 2025 | Sep 4, 2025 | A · derivative | 15,000 | $1.64 | $24,600 | 15,000 | No | Form 4 |
| Schwartz Aharon | Sep 3, 2025 | Sep 4, 2025 | A | 7,500 | not reported | not reported | 7,500 | No | Form 4 |
| Schwartz Aharon | Sep 3, 2025 | Sep 4, 2025 | A · derivative | 15,000 | $1.64 | $24,600 | 15,000 | No | Form 4 |
| Boudes Pol F | Sep 3, 2025 | Sep 4, 2025 | A | 7,500 | not reported | not reported | 7,500 | No | Form 4 |
| Boudes Pol F | Sep 3, 2025 | Sep 4, 2025 | A · derivative | 15,000 | $1.64 | $24,600 | 15,000 | No | Form 4 |
| Melincoff Gwen A | Sep 3, 2025 | Sep 4, 2025 | A | 7,500 | not reported | not reported | 7,500 | No | Form 4 |
| Melincoff Gwen A | Sep 3, 2025 | Sep 4, 2025 | A · derivative | 15,000 | $1.64 | $24,600 | 15,000 | No | Form 4 |
| Elze Christian | Sep 3, 2025 | Sep 4, 2025 | A | 7,500 | not reported | not reported | 7,500 | No | Form 4 |
| Elze Christian | Sep 3, 2025 | Sep 4, 2025 | A · derivative | 15,000 | $1.64 | $24,600 | 15,000 | No | Form 4 |
| Forster Eliot | Sep 3, 2025 | Sep 4, 2025 | A | 7,500 | not reported | not reported | 7,500 | No | Form 4 |
| Forster Eliot | Sep 3, 2025 | Sep 4, 2025 | A · derivative | 15,000 | $1.64 | $24,600 | 15,000 | No | Form 4 |
| Schwartz Aharon | Jun 10, 2025 | Aug 12, 2025 | P | 129,000 | $1.60 | Purchase +$206,400 | 303,000 | No | Form 4 |
| Rubin EyalSr. VP and CFO | Sep 23, 2024 | Nov 5, 20244/A | A | 90,909 | not reported | not reported | 660,909 | No | Form 4/A |
| Naos YaronSr. VP, Operations | Sep 23, 2024 | Sep 24, 2024 | A · derivative | 100,000 | $1.10 | $110,000 | 100,000 | No | Form 4 |
| Bashan DrorPRESIDENT AND CEO | Apr 1, 2024 | Apr 3, 2024 | A | 263,960 | not reported | not reported | 2,149,418 | No | Form 4 |
| Bashan DrorPRESIDENT AND CEO | Oct 19, 2023 | Oct 20, 2023 | P | 48,387 | $1.40 | Purchase +$67,742 | 116,387 | No | Form 4 |
| Bashan DrorPRESIDENT AND CEO | Oct 19, 2023 | Oct 20, 2023 | P | 16,129 | $1.41 | Purchase +$22,742 | 132,516 | No | Form 4 |
| Ben Zvi Shmuel | Sep 29, 2023 | Oct 3, 2023 | A · derivative | 61,676 | $1.66 | $102,382 | 61,676 | No | Form 4 |
| Schwartz Aharon | Sep 29, 2023 | Oct 3, 2023 | A · derivative | 61,676 | $1.66 | $102,382 | 61,676 | No | Form 4 |
| Bar-Shalev Amos | Sep 29, 2023 | Oct 3, 2023 | A · derivative | 61,676 | $1.66 | $102,382 | 61,676 | No | Form 4 |
| Melincoff Gwen A | Sep 29, 2023 | Oct 3, 2023 | A · derivative | 61,676 | $1.66 | $102,382 | 61,676 | No | Form 4 |
| Boudes Pol F | Sep 29, 2023 | Oct 3, 2023 | A · derivative | 61,676 | $1.66 | $102,382 | 61,676 | No | Form 4 |